Banner
Banner
News

GTCbio and the Advisory Board would like to invite you the 2nd Kinase Inhibitors Design & Screening Conference. This event takes place May 12-13, 2016 in Berlin, Germany. The conference brings together industry leaders from major pharmaceuticals, biotech companies, and top researchers from academia to provide a timely and critical update on significant kinase inhibitors and to better understand current trends for drug design and screening processes. This meeting’s discussion and presentations will circle around recent developments in allosteric kinase inhibitors, covalent inhibitor strategies, irreversible and RAF inhibitors, mechanisms of kinase inhibitor resistance, and mutation-focused approaches towards kinase inhibition.

Session topics include:

I. Novel Tools & Technological Advances in Kinase Inhibitor Development
II. Target Identification & Validation
III. Biomarkers in Kinase Drug Discovery
IV. Kinase Inhibitors for CNS Indications
V. Kinase Inhibitor Design & Overcoming Resistance and Selectivity- Joint session with 10th Drug Design & Medicinal Chemistry

Conference Dates: May 12-13, 2016

https://www.gtcbio.com/conferences/kinase-inhibitors-design-screening-overview

We invite you to attend the 11th Protein Kinases in Drug Discovery Conference, which will take place February 29 - March 1, 2016 in San Diego, CA.

Over the past decades, protein kinases have proven to be an important class of drug targets for the pharmaceutical industry. This meeting seeks to create a forum for scientists from both industry and academia to gather and discuss the most recent advances in kinase inhibitor research. Leading researchers will present on hot topics such as reversible and irreversible inhibitors, kinome selectivity and translation, kinase evolution and resistance, and many more. In addition to scientific talks, dedicated networking sessions will allow attendees to better dialogue on how kinase inhibitor discovery will continue to expand.

Sessions include:
I. Novel Approaches in Kinase Targeting
II. New Tools and Technologies in Kinase Drug Discovery
III. Kinome Selectivity and Translation to Clinical Safety
IV. Kinase Evolution & Development of Resistance to Kinase Inhibitors

Conference Dates: February 29 - March 1, 2016

https://www.gtcbio.com/conferences/protein-kinases-drug-discovery-overview

We are pleased to invite you to GTCbio's 6th Ubiquitin Research & Drug Discovery Conference, which will take place February 29 - March 1, 2016 in San Diego, CA. This conference will provide a forum for researchers from industry and academia to learn about recent advances in basic science and drugs that target the ubiquitin/proteasome system. Hot topics such as autophagy in cancer, developments with deubiquitinating enzymes, and novel drug targets in the ubiquitin system will be covered.

Please join us not only for updates on the latest scientific research, but also for networking sessions between colleagues from both industry and academia in order to get the most comprehensive exchange of ideas.

Session Topics:

  1. Advances in Ubiquitin-like Modifications
  2. Ubiquitin Pathways in Neurodegenerative Disorders
  3. Ubiquitin Proteasome System & Oncology
  4. Autophagy in Cancer & Metabolic Diseases
  5. Novel Drug Targets in the Ubiquitin System
  6. Deubiquitinating Enzymes as Drug Targets

Conference Dates: February 29 - March 1, 2016

https://www.gtcbio.com/conferences/ubiquitin-research-drug-discovery-overview

2nd International Conference on Food Safety and Regulatory Measures

OMICS International Conferences invites all the participants from all over the world to attend ‘2nd International Conference on Food safety and Regulatory Measures ‘during June 06-08, 2016 at London, UK which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.

Food Safety-2016 refers to the conditions and practices that preserve the quality of food to prevent contamination and food-borne illnesses. The Food Safety and Inspection Service of the USDA educates consumers about the importance of safe food handling and how to reduce the risks associated with foodborne illness.Responsibility for food safety is shared by everyone involved with food from production to consumption, including growers, processors, regulators, distributors, retailers and consumers

OMICS International organizes a conference series of 1000+ Global Events inclusive of 300+ Conferences, 500+ Upcoming and Previous Symposiums and Workshops in USA, Europe & Asia with support from 1000 more scientific societies and publishes 700+ Open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members.

Why to attend???

Food Safety -2016 mainly focuses on Foodborne illness continues to be an urgent issue across the United States. In fact, the CDC estimates that each year roughly 1 out of 6 Americans (or 48 million people) get sick, 128,000 are hospitalized, and 3,000 die of foodborne diseases.   The Food Safety and Inspection Service of USDA educates consumers about the importance of safe food handling and how to reduce the risk associated with foodborne illness for future generation and aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results. Food Safety -2016 aims to promote various researches on food safety among scientists, academia and industries.

With the presence of highly affiliated personalities, researchers, scientists around the globe focused on food production, this conference is providing the platform for learning and sharing the new developments in this field.  This is the place to meet the current and potential speakers and receive the name recognition.

Target Audience:

  • Presidents
  • Vice presidents/Directors
  • Academicians
  • Researchers
  • Scientists
  • Business delegates
  • Experts
  • Departmental managers
  • Professors and students from Academia

http://foodsafety-hygiene.conferenceseries.com/

Currently, pharmaceutical companies assemble their own in-house databases of pharmacological and physicochemical data resources. Open PHACTS integrates data from multiple publicly-available databases, giving you access to a vast linked data resource through a stable, integrated infrastructure.

This allows researchers to build better analysis pipelines — and gives researchers in academia and smaller companies unprecedented access to pharmacological data resources.

What do we mean by “linked data”?

Pharmacological entities — compounds, target pathways, etc. — each have multiple different identifiers used by different data providers. This makes finding information about an entity a complicated, fragmented process. For example, Sorafenib has the following identifiers:

In fact, Sorafenib has over 30 of these identifiers, each linking to a different data provider with different bits of information about Sorafenib’s properties and actions.

The Open PHACTS Discovery Platform integrates data associated with each identifier, so that you can browse and query interoperable data about Sorafenib from multiple sources in one place. This allows you to drastically increase the efficiency of your existing research and analysis workflows.

What sort of questions can Open PHACTS answer?

The potential of Open PHACTS to facilitate research is vast. Our example Workflows demonstrate some of the questions that Open PHACTS can help answer for you as a researcher.

We also provide access to integrated data via the Open PHACTS Explorer and various other Applications for browsing and querying data.

More Articles...

Page 8 of 36

8
http://www.zelinsky.com
http://www.timtec.net
Banner
Banner
Banner

Upcoming Events

There are no upcoming events currently scheduled.
View full calendar
FacebookMySpaceTwitterDiggDeliciousStumbleuponGoogle BookmarksRedditNewsvineTechnoratiLinkedinMixxRSS Feed